709
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Seroprevalence for vaccine-preventable diseases among Italian healthcare workers

, , , , , & show all
Pages 1342-1346 | Received 05 Jun 2020, Accepted 29 Aug 2020, Published online: 05 Oct 2020

References

  • Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC). Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(RR–7):1–45. World Health Organization. Weekly epidemiological record. April 2017. No 17, 2017, 92, 205–228.
  • World Health Organization (WHO). Occupational health. Health workers. Health worker occupational health; [ accessed 2014 May 14]. http://www.who.int/occupational_health/topics/hcworkers/en/.
  • Porretta A, Quattrone F, Aquino F, Pieve G, Bruni B, Gemignani G, Vatteroni ML, Pistello M, Privitera GP, Lopalco PL, et al. A nosocomial measles outbreak in Italy, February-April 2017. Euro Surveill. 2017;22(33):30597. doi:10.2807/1560-7917.ES.2017.22.33.30597.
  • Baxi R, Mytton OT, Abid M, Maduma-Butshe A, Iyer S, Ephraim A, Brown KE, O’Moore É. Outbreak report: nosocomial transmission of measles through an unvaccinated healthcare worker—implications for public health. J Public Health (Bangkok). 2014 Sept;36(3):375–81. doi:10.1093/pubmed/fdt096.
  • Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial transmission of measles: an updated review. Vaccine. 2012;30(27):3996–4001. ISSN 0264-410X. doi:10.1016/j.vaccine.2012.04.023.
  • Barbadoro P, Marigliano A, Di Tondo E, Di Tondo E, De Paolis M, Martini E, Prospero E, Marcello MD. Measles among healthcare workers in a teaching hospital in central Italy. J Occup Health. 2012;54(4):336–39. doi:10.1539/joh.12-0016-br.
  • Antela A, Fortún J, Navas E, Hermida JM, Fernández-Muñoz R, Guerrero A. Varicela nosocomial: estudio de un brote epidémico entre pacientes inmunodeprimidos [Nosocomial varicella: study of an epidemic outbreak among immunosuppressed patients]. Enferm Infecc Microbiol Clin. 1991;9:357–60.
  • Ministero della Salute Piano Nazionale Prevenzione Vaccinale. 2017–2019 (PNPV). World Health Organization. Guidelines on verification of measles elimination in the Western Pacific Region. WHO Library; 2013. [accessed 17 January 2017]. http://www.salute.gov.it/imgs/C_17_pub-blicazioni_2571_allegato.pdf.
  • Filia A, Bella A. Centro nazionale per la prevenzione delle malattie e la promozione della salute. Aspetti epidemiologici in Italia; 2017 March.
  • Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998;15:1–8. doi:10.1016/S0749-3797(98)00003-8.
  • Coppeta L, Pompei A, Balbi O, De Zordo LM, Mormone F, Policardo S, Lieto P, Pietroiusti A, Magrini A. Persistence of immunity for hepatitis B virus among healthcare workers and italian medical students 20 years after vaccination. Int J Environ Res Public Health. 2019;16(9):1515. doi:10.3390/ijerph16091515.
  • Stefanati A, Bolognesi N, Sandri F, Dini G, Massa E, Montecucco A, Lupi S, Gabutti G. Long-term persistency of hepatitis B immunity: an observational cross-sectional study on medical students and resident doctors. J Prev Med Hyg. 2019 [Published 2019 Sept 30];60(3):E184–E190. doi:10.15167/2421-4248/jpmh2019.60.3.1315.
  • Centers for Disease Control and Prevention (CDC). Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP). MMWR. 2013 June 14;62(RR04):1–34.
  • Gallone MS, Germinario C, Larocca A, Tafuri S. Long time immunogenicity of measles vaccine in the vaccination era: an open question. Hum Vaccin Immunother. 2017;13(1):117–19. doi:10.1080/21645515.2016.1227519.
  • Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008 Apr 1;197(7):950–56. doi:10.1086/528993.
  • Marin M, Marlow M, Moore KL, Patel M. Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak. MMWR Morb Mortal Wkly Rep. 2018;67:33–38. doi:10.15585/mmwr.mm6701a7.
  • Leone Roberti Maggiore U, Scala C, Toletone A, Debarbieri N, Perria M, D’Amico B, Montecucco A, Martini M, Dini G, Durando P, et al. Susceptibility to vaccine-preventable diseases and vaccination adherence among healthcare workers in Italy: A cross-sectional survey at a regional acute-care university hospital and a systematic review. Hum Vaccin Immunother. 2017;13(2):470‐476. doi:10.1080/21645515.2017.1264746.
  • Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports: morbidity and mortality weekly report. Recomm Rep. 2007 Jun 22;56(RR–4):1–40.
  • Rieck T, Feig M, An der Heiden M, Siedler A, Wichmann O. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro surveillance: bulletin Europeen sur les maladies transmissibles = Eur commun dis bull. 2017 Apr 27;22:17.
  • Coppeta L, Biondi G, Lieto P, Pietroiusti A. Evaluation of immunity to measles in a cohort of medical students in Rome, Italy. Vaccines (Basel). 2019 [Published 2019 Dec 13];7(4):214. doi:10.3390/vaccines7040214.
  • Coppeta L, Balbi O, Baldi S, Pietroiusti A, Magrini A. Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among health care workers. Hum Vaccin Immunother. 2019;15(5):1135–1138. doi:10.1080/21645515.2018.1564442.
  • Asari S, Deguchi M. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in healthcare workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control. 2003;31:157–62. doi:10.1067/mic.2003.16.
  • National Integrated Measles-Rubella Surveillance System. Measles in Italy: weekly bullettin. Week. Sept 25–Oct 1; 2017. p. W39.
  • Campagna M, Bacis M, Belotti L, Biggi N, Carrer P, Cologni L, Gattini V, Lodi V, Magnavita N, Micheloni G, Negro C. Le malattie esantematiche (Morbillo, Varicella, Rosolia e Parotite). Focus su screening e sorveglianza sanitaria dei lavoratori della sanità: risultati e prospettive di un gruppo di lavoro multicentrico [Exanthemic diseases (measles, chickenpox, rubella and parotitis). Focus on screening and health surveillance of health workers: results and perspectives of a multicenter working group]. G Ital Med Lav Ergon. 2010;32(3):298–303.
  • Carrer P, Micheloni G, Campagna M, Bacis M, Belotti L, Biggi N, Cologni L, Gattini V, Fostinelli J, Lodi V, et al. Focus sulla sorveglianza sanitaria dei lavoratori della sanità esposti ad agenti biologici trasmissibili per via ematogena: risultati e prospettive di un gruppo di lavoro multicentrico [Focus on health surveillance of health workers exposed to blood-transmissible biological agents: results and perspectives of a multicenter working group]. G Ital Med Lav Ergon. 2010;32(3):249–55.
  • WHO. Manual for the laboratory diagnosis of measles and rubella virus infection. Second Edition; 2007.
  • Holka J, Pawlak K, Ciepiela O. Cent. Seroprevalence of IgG antibodies against measles in a selected Polish population - do we need to be re-vaccinated? Eur J Immunol. 2019;44(4):380–83. doi:10.5114/ceji.2019.92789. Epub 2020 Jan 20.
  • Taddei C, Ceccherini V, Niccolai G, Porchia BR, Boccalini S, Levi M, Tiscione E, Santini MG, Baretti S, Bonanni P, et al. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. Hum Vaccin Immunother. 2014;10:2612–22. doi:10.4161/21645515.2014.970879.
  • Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. Int J Infect Dis. 2012;206:1542–48. doi:10.1093/infdis/jis568.
  • Coppeta L, Morucci L, Pietroiusti A, Magrini A. Cost-effectiveness of workplace vaccination against measles. Hum Vaccin Immunother. 2019;15(12):2847–50. doi:10.1080/21645515.2019.1616505.
  • Coppeta L, Pietroiusti A, Lieto P, Ferraro M, Grelli S, Stillo M, Magrini A. Measles immunity in an Italian teaching hospital. Occup Med (Lond). 2019;69(2):143–145. doi:10.1093/occmed/kqy132.
  • Coppeta L, Pietroiusti A, Morucci L, Neri A, Ferraro M, Magrini A. Workplace vaccination against measles in a teaching hospital of Rome. J Hosp Infect. 2019;101(3):364‐365. doi:10.1016/j.jhin.2018.11.022.
  • Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis. 2002 Mar 15;34(6):774–79. doi:10.1086/338959.
  • Scatigna M, Fabiani L, Micolucci G, Santilli F, Mormile P, Giuliani AR. Attitudinal variables and a possible mediating mechanism for vaccination practice in health care workers of a local hospital in L’Aquila (Italy). Hum Vaccin Immunother. 2017;13(1):198–205. doi:10.1080/21645515.2016.1225638.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763‐1773. doi:10.4161/hv.24657.
  • Genovese C, Picerno IAM, Trimarchi G, Cannavò G, Egitto G, Cosenza B, Merlina V, Icardi G, Panatto D, Amicizia D, et al. Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy. J Prev Med Hyg. 2019;60(1):E12–E17. doi:10.15167/2421-4248/jpmh2019.60.1.1097.
  • Bianchi FP, Mascipinto S, Stefanizzi P, De Nitto S, Germinario CA, Lopalco P, Tafuri S. Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 9]. Expert Rev Vaccines. 2020;1–9. doi:10.1080/14760584.2020.1791091.
  • LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S, Gargiullo P. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adol Med. 2007;161(3):294–301. doi:10.1001/archpedi.161.3.294.
  • Bianchi FP, Gallone MS, Gallone MF, Larocca AMV, Vimercati L, Quarto M, Tafuri S. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: an Italian study among medical students. J Viral Hepat. 2019;26(1):136–44. doi:10.1111/jvh.13001.
  • Bianchi FP, Stefanizzi P, De Nitto S, Larocca AMV, Germinario C, Long-term TS. Immunogenicity of Measles Vaccine: an Italian Retrospective Cohort Study. J Infect Dis. 2020;221(5):721–28. doi:10.1093/infdis/jiz508.
  • Bianchi FP, De Nitto S, Stefanizzi P, Larocca AMV, Germinario CA, Tafuri S. Long time persistence of antibodies against Mumps in fully MMR immunized young adults: an Italian retrospective cohort study [published online ahead of print, 2020 Mar 18]. Hum Vaccin Immunother. 2020:1–7. doi:10.1080/21645515.2020.1735861.
  • Bianchi FP, De Nitto S, Stefanizzi P, Larocca AMV, Germinario CA, Tafuri S. Immunity to rubella: an Italian retrospective cohort study. BMC Public Health. 2019 [Published 2019 Nov 8];19(1):1490. doi:10.1186/s12889-019-7829-3.
  • Connors CM, Miller NC, Krause VL. Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin. Aust N Z J Public Health. 1998;22:143–45. doi:10.1111/j.1467-842X.1998.tb01159.x.
  • Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals–a review of studies on attitudes and predictors. Vaccine. 2009;27:3935–44. doi:10.1016/j.vaccine.2009.03.056.
  • Jelleyman T, Ure A. Attitudes to immunisation: a survey of health professionals in the Rotorua District. N Z Med J. 2004;117:U769.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.